Related Experiment Video
Updated: Jan 27, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Acetylation-mediated fluconazole inactivation: A novel antifungal resistance mechanism
Ludmila Gouveia-Eufrasio1, Gustavo José Cota de Freitas1, Danielle Letícia da Silva1
1Department of Microbiology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Av. Pres. Antônio Carlos, 6627, Pampulha, Belo Horizonte, MG 31270-901, Brazil.
Abstract:
Antifungal resistance is considered a global health threat. However, enzymatic inactivation of antifungals, a common mechanism seen in antibacterial resistance, has not yet been described in fungi. From a One Health perspective, this study demonstrates that Cryptococcus deuterogattii and C. neoformans, the leading agents of cryptococcosis, enzymatically inactivate fluconazole. Agrochemicals induce the overexpression of genes that code for acetyltransferases, specifically GCN5 and NAT10. These enzymes catalyze the acetylation of fluconazole into O-acetyl-fluconazole. This metabolite is unable to properly bind to 14-α-demethylase, the azole target, abolishing the antifungal activity. GCN5 and NAT10 inhibitors constrained acetylation and restored fluconazole activity, highlighting their potential as therapeutic adjuvants. The same phenotype was observed in other fungal species, suggesting broader relevance. Furthermore, O-acetyl-fluconazole was also detected in cerebrospinal fluid from cryptococcal meningitis patients undergoing fluconazole treatment. These findings reveal a previously unrecognized antifungal resistance mechanism and suggest that environmental traits shape clinically relevant resistance through conserved enzymatic pathways.
Insights
Fungi like Cryptococcus can deactivate fluconazole using enzymes, a new antifungal resistance mechanism. This discovery, linked to agrochemicals, offers potential new antifungal therapies.
Area of Science:
- Mycology
- Antimicrobial Resistance
- Biochemistry
Background:
- Antifungal resistance is a growing global health concern.
- Enzymatic inactivation of antifungals is a known mechanism in bacteria but not previously described in fungi.
- Cryptococcus species are major causes of cryptococcosis, a serious fungal infection.
Purpose of the Study:
- To investigate if fungi, specifically Cryptococcus species, can enzymatically inactivate fluconazole.
- To identify the enzymes and mechanisms involved in fluconazole inactivation.
- To explore the clinical relevance and potential therapeutic strategies against this resistance mechanism.
Main Methods:
- Investigated fluconazole inactivation by Cryptococcus deuterogattii and Cryptococcus neoformans.
- Analyzed gene expression changes in response to agrochemical exposure.
- Identified enzymes (GCN5, NAT10) responsible for fluconazole acetylation.
- Assessed the impact of O-acetyl-fluconazole on the binding affinity to 14-α-demethylase.
- Tested the efficacy of GCN5 and NAT10 inhibitors in restoring fluconazole activity.
- Detected O-acetyl-fluconazole in patient cerebrospinal fluid samples.
Main Results:
- Cryptococcus species enzymatically inactivate fluconazole into O-acetyl-fluconazole.
- Agrochemicals induce overexpression of GCN5 and NAT10, leading to fluconazole acetylation.
- O-acetyl-fluconazole cannot bind effectively to 14-α-demethylase, rendering fluconazole inactive.
- Inhibitors of GCN5 and NAT10 restored fluconazole's antifungal activity.
- The same resistance mechanism was observed in other fungal species.
- O-acetyl-fluconazole was detected in the cerebrospinal fluid of patients with cryptococcal meningitis.
Conclusions:
- A novel mechanism of antifungal resistance through enzymatic inactivation of fluconazole has been discovered in fungi.
- Environmental factors, such as agrochemicals, can influence clinically relevant antifungal resistance via conserved enzymatic pathways.
- GCN5 and NAT10 inhibitors show promise as adjuvants to overcome fluconazole resistance in fungal infections.
Related Concept Videos
X-Inactivation
Activation and Inactivation of G Proteins
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Resistivity
Resistance

